Although many studies have shown that increased LOXL2 expression is associated with lymph node metastasis, lymphatic invasion, and advanced tumor stage [10, 11], IHC staining of LOXL2 was not associated with clinicopathologic variables in this study. Here, LOXL2 is linked to neoplasm.